Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Penicillin-binding proteins II and III are essential **bacterial enzymes** involved in the final stages of **cell wall peptidoglycan synthesis**, specifically catalyzing the cross-linking of glycan chains through their **transpeptidase activity**. These proteins are found on the inner membrane of bacteria and are critical for maintaining cell shape and integrity. They serve as primary targets for β-lactam antibiotics such as penicillins and cephalosporins. Inhibition by these drugs occurs via covalent binding to an active site serine residue within a conserved SXXK motif, blocking enzymatic function necessary for bacterial growth and division[1][2][3]. For example, inhibition of PBP3 leads to filamentous growth due to failed cell separation during division[5]. Resistance can arise through mutations that alter drug binding or expression of alternative PBPs with reduced affinity for β-lactams.\n\nNote on nomenclature: "Penicillin-binding protein II/III" refers collectively to two related but distinct enzymes—PBP2 is typically associated with maintenance of rod shape during elongation; PBP3 is essential for septum formation during cell division. Both are considered high-molecular-mass class B PBPs with similar domain structures but distinct physiological roles depending on species context[1][5].
Covalent acylation of the active site serine by β-lactam antibiotics inhibits the transpeptidase activity required for peptidoglycan cross-linking in bacterial cell walls[1][2][3].\n - This leads to impaired cell wall synthesis and ultimately bacterial lysis.
2 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Penicillin-binding protein II (PBP2 (for Penicillin-binding protein II), PBP3 (for Penicillin-binding protein III)).